Smallpox

Active Research Protocols

  1. 03-I-0090 – Immune Responses to Vaccinia Virus Vaccination
  2. 08-I-0093 – A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014